(Q43631912)

25 November 2017

Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia (English)

1 reference

25 November 2017

0 references

0 references

Hager K

1

1 reference

25 November 2017

Marahrens A

2

1 reference

25 November 2017

Kenklies M

3

1 reference

25 November 2017

Riederer P

4

1 reference

25 November 2017

Münch G

5

1 reference

25 November 2017

1 June 2001

1 reference

Archives of Gerontology and Geriatrics

25 November 2017

1 reference

25 November 2017

32

1 reference

25 November 2017

3

1 reference

25 November 2017

275-282

1 reference

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

1 reference

7 January 2021

Abnormalities of Glucose Metabolism in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Interactions among antioxidants in health and disease: vitamin E and its redox cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

alpha-Lipoic acid as a biological antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Neuroprotection by the metabolic antioxidant alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

Diabetes and dementia in long-term care.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900104-2

7 January 2021

10.1016/S0167-4943(01)00104-2

Identifiers

DOI

1 reference

25 November 2017

1 reference